<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26446216</article-id>
<article-id pub-id-type="pmc">6605382</article-id>
<article-id pub-id-type="publisher-id">2217-15</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.2217-15.2015</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group>
<subject>Cellular/Molecular</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased Dosage of High-Affinity Kainate Receptor Gene <italic>grik4</italic> Alters Synaptic Transmission and Reproduces Autism Spectrum Disorders Features</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Aller</surname>
<given-names>M. Isabel</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6447-9896</contrib-id>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pecoraro</surname>
<given-names>Valeria</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paternain</surname>
<given-names>Ana V.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canals</surname>
<given-names>Santiago</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2175-8139</contrib-id>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lerma</surname>
<given-names>Juan</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7838-5199</contrib-id>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<aff id="aff1">Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas, Universidad Miguel Hernández de Elche, 03550 San Juan de Alicante, Spain</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Juan Lerma,
<addr-line>Instituto de Neurociencias, CSIC-UMH, 03550 San Juan de Alicante, Spain.</addr-line><email>jlerma@umh.es</email></corresp>
<fn fn-type="con">
<p>Author contributions: M.I.A. and J.L. designed research; M.I.A., V.P., and A.V.P. performed research; S.C. contributed unpublished reagents/analytic tools; M.I.A., V.P., and A.V.P. analyzed data; J.L. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>7</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>35</volume>
<issue>40</issue>
<fpage>13619</fpage>
<lpage>13628</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>6</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>8</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 the authors 0270-6474/15/3513619-10$15.00/0</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri xlink:href="zns04015013619.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The understanding of brain diseases requires the identification of the molecular, synaptic, and cellular disruptions underpinning the behavioral features that define the disease. The importance of genes related to synaptic function in brain disease has been implied in studies describing <italic>de novo</italic> germline mutations and copy number variants. Indeed, <italic>de novo</italic> copy number variations (deletion or duplication of a chromosomal region) of synaptic genes have been recently implicated as risk factors for mental retardation or autism. Among these genes is <italic>GRIK4</italic>, a gene coding for a glutamate receptor subunit of the kainate type. Here we show that mice overexpressing <italic>grik4</italic> in the forebrain displayed social impairment, enhanced anxiety, and depressive states, accompanied by altered synaptic transmission, showing more efficient information transfer through the hippocampal trisynaptic circuit. Together, these data indicate that a single gene variation in the glutamatergic system results in behavioral symptomatology consistent with autism spectrum disorders as well as in alterations in synaptic function in regions involved in social activity. Autistic features of these mice represent powerful tools for improving diagnosis and testing of specific treatments targeting abnormalities in glutamatergic signaling related to autism spectrum disorders.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> A genetic overlap exists between autism spectrum disorders (ASD), currently thought to represent a continuum of the same disorder with varying degrees of severity, and other neurodevelopmental and neuropsychiatric endophenotypes. We show that the duplication of a single gene coding for a high-affinity kainate receptor subunit (i.e., <italic>grik4</italic>) in a limited area of the brain recapitulates behavioral endophenotypes seen in humans diagnosed with autism (anhedonia, depression, anxiety, and altered social interaction), including some humans with <italic>GRIK4</italic> duplications. Therefore, it should be possible to use mice overexpressing <italic>grik4</italic> to directly address circuit dysfunctions associated with ASDs and test specific treatments of autism-related behaviors.</p>
</abstract>
<kwd-group>
<kwd>anxiety</kwd>
<kwd>autism</kwd>
<kwd>depression</kwd>
<kwd>GluK4</kwd>
<kwd>
<italic>grik4</italic>
</kwd>
<kwd>high-affinity kainate receptor</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>coverarticle</meta-name>
<meta-value>true</meta-value>
</custom-meta>
<custom-meta>
<meta-name>twij</meta-name>
<meta-value>true</meta-value>
</custom-meta>
<custom-meta>
<meta-name>special-property</meta-name>
<meta-value>cellular</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>